Cocer Peptides fɛ 
a bɛ kalo 1 bɔ
BƐƐRƐ KUNNAFONIW NI FƐRƐW KUNNAFONIW BƐƐ MIN BƐ NI WEBSITE KAN NA, U BƐ KUNNAFONIW FƆLƆ DƆRƆN NI KALANSENW YE.
Fɛn minnu bɛ di nin siti in kan, olu dabɔra ɲininiw dɔrɔn kama in vitro. Sɛgɛsɛgɛli in vitro (latinkan na: *glasi kɔnɔ*, o kɔrɔ ye gilasi kɔnɔ) bɛ kɛ hadamaden farikolo kɔkan. Nin fura ninnu tɛ furaw ye, Ameriki ka dumuniko ni furako ɲɛmɔgɔso (FDA) ma sɔn u ma, wa u man kan ka kɛ ka furakɛli bana, bana walima bana si bali, k’a furakɛ, walima k’a furakɛ. A dagalen don kosɛbɛ sariya fɛ ka nin fɛn ninnu don hadamaden walima bagan farikolo la cogo o cogo.
Fasa kɛra foroba kɛnɛyako gɛlɛn ye ka taa a fɛ diɲɛ kɔnɔ, a bɛ nɔ jugu caman bila mɔgɔw farikolo kɛnɛya la, i n’a fɔ dusukun ni jolisiraw banaw, sukarodunbana, ani bana basigilen wɛrɛw. San laban ninnu na, GLP-1 furaw bɔra kɛnɛ kan ka kɛ furakɛli fɛɛrɛ ye min bɛ layidu ta fasa kunbɛnni siratigɛ la.
Jaa 1 GLP-1 ka girinya dɔgɔyali fɛɛrɛ minnu bɛ se ka kɛ. GI, Kɔnɔnatumuw; GLP-1, Glucagon ɲɔgɔnna pepitiri-1; GLP-1R, Glucagon ɲɔgɔnna pepitiri-1 minɛbaga.
GLP-1 furaw baaracogo fasa furakɛli la
GLP-1 ye pepitiri ye min bɛ sɔrɔ kɔnɔna na, min bɛ bɔ L selilɛriw fɛ banakɔtaa kɔnɔbara basigilen na. GLP-1 furaw, n’u bɛ wele fana ko GLP-1 minɛbaga agonistes (GLP-1 RAs), olu bɛ GLP-1 farikolo ta fan fɛ nɔw ladege ni GLP-1 minɛbaga ni a duguma taamasiɲɛw siraw baara ye, o la, u bɛ farikoloɲɛnajɛ nɔ suguya caman kɛ minnu bɛ dɛmɛ don farikolo girinya kunbɛnni na.
Inisɔn bɔli sabatili : GLP-1 RAw bɛ inisɔndiya bɔli lawuli ka bɔ pankreyasi β selilɛriw la cogo la min bɛ bɔ sukaro la. Ni joli sukaro hakɛ wulila, GLP-1 RAw bɛ siri GLP-1 minɛbagaw la pankreyasi β selilɛriw sanfɛ, ka selilɛri kɔnɔ taamasiɲɛw siraw baara walasa ka inisɔndiya sɔrɔli ni a bɔli sabati, o bɛ joli sukaro hakɛ dɔgɔya. Joli sukaro hakɛ sabatili bɛ dɛmɛ ka tulu sɔrɔli ni a marali dɔgɔya, ka dumuni nege caya ani ka girinya bali min bɛ sɔrɔ joli sukaro jiginni fɛ.
Dumuni nege dabila : GLP-1 RAw bɛ baara kɛ farikolo cɛmancɛ la, kɛrɛnkɛrɛnnenya la kunsɛmɛ yɔrɔw minnu bɛ tali kɛ dumuni nege labɛnni na, i n’a fɔ hipotalamus. Ni u sirilen don GLP-1 minɛbagaw la hipotalamus (hypothalamus) senkɔniw sanfɛ, u bɛ neuropeptide bɔli ɲɛnabɔ, i n’a fɔ ka dumuni nege lawulili pepitiriw bɔli dɔgɔya ani ka dɔ fara dumuni nege bali pepitiriw jirali kan, o la, u bɛ fasa dusukunnata bila mɔgɔ la, ka dumuni dunta dɔgɔya, ani ka se ka girinya kunbɛn.
Kɔnɔbara lankolonya bilali kɔfɛ : GLP-1 RAw bɛ kɔnɔbara kɔnɔfɛnw don banakɔtaa fitini kɔnɔ cogo min na, o bɛ dɔ bɔ, o bɛ dumuni to kɔnɔbara la waati janya ani ka fasa dusukunnata sabatili lase mɔgɔ ma. O kɔnɔbara lankolonya kɔfɛ, o tɛ dumuni hakɛ dɔgɔya dɔrɔn, nka a bɛ joli sukaro hakɛ fana sabati, ka joli sukaro jiginni bali dumuni kɔfɛ, o la, a bɛ dɔ bɔ tulu dalajɛli la.
Ɲɛjirali 1 GLP-1 minɛbagaw ka agonistew jateminɛcogo jateminɛcogo: u danfara, furaw lakanani, ani u nafa. GI, Kɔnɔnatumuw; GLP-1R, Glucagon ɲɔgɔnna pepitiri-1 minɛbaga; PEG, Polietilɛni gilikɔli.
GLP-1 furaw tali fasa furakɛli la
Balikuw ka fasa furakɛli : Balikuw ka fasa furakɛli la, GLP-1 RAw ye nɔba sɔrɔ. Semaglutide ka kɛnɛyako sɛgɛsɛgɛli Fasa III dafara, ni jaabiw y’a jira ko a bɛ mɔgɔ farikolo girinya dɔgɔyali nɔba bila. STEP miligaramu 2,4/dɔgɔkun semaglutidi porozɛ kɔnɔ, banabagatɔw ye girinya dɔgɔya kosɛbɛ, o ye GLP-1 RAw nafa jira ka t’a fɛ balikuw ka fasa furakɛli la. A ka ca a la, nin fura ninnu bɛ kɛ ka kɛ farikolojidɛsɛ porogaramu bɛɛ lajɛlen dɔ ye, ka fara dumunikɛcogo kɔlɔsili ni farikoloɲɛnajɛ danmadɔ kan, walasa ka farikolojidɛsɛ sɔrɔcogo ɲuman sɔrɔ.
Denmisɛnw ka fasa furakɛli : Kɔsa in na, sɛgɛsɛgɛliw y’a jira ko GLP-1 furaw i n’a fɔ ɛkzɛnatidi, semaglutidi ani liraglutide kɛra ka denmisɛnninw ka fasa banaw furakɛ, i n’a fɔ fasa jugumanba, fasa min bɛ sɔrɔ ni ovari polycystique syndrome (PCOS) ye, ani fasa hipotalamu. Misali la, sɛgɛsɛgɛliw y’a jira ko fura ninnu bɛ nɔ dɔ bila denmisɛnw ka girinya kunbɛnni na, ka dɛmɛ don ka farikoloɲɛnajɛ kɛcogo ɲɛ, ani ka fɛɛrɛ kuraw di denmisɛnw ka fasa furakɛli ma.
Fasa furakɛli jamana kɛrɛnkɛrɛnnenw na - PCOS banabagatɔw : Ovari polycystique syndrome (PCOS) ye kɔnɔbolibana ye min ka teli ka kɛ musow la minnu si bɛ bangekɔlɔsi la, wa fasa ka ca PCOS banabagatɔw la. GLP-1 RAw nafa kɛrɛnkɛrɛnnen don fasa furakɛli la PCOS banabagatɔw la. Kɔlɔsiliw y’a jira ko GLP-1 furakɛli tɛ dɔ bɔ PCOS banabagatɔw girinya dɔrɔn na, nka a bɛ inisɔndiya fana ɲɛ, ka jolidɛsɛ dɔgɔya, ani ka dɔ fara hali kɔnɔta hakɛ kan ani ka kɔnɔta kɛ in vitro. O bɛ GLP-1 RAw kɛ furakɛli fɛɛrɛ ye min bɛ layidu ta kosɛbɛ PCOS banabagatɔ fasalenw bolo, o bɛ fɛɛrɛ kuraw di u ka kɛnɛya ni u ka bange sabatili ma.
Kuncɛli
Kuma surun na, GLP-1 furaw, i n’a fɔ fanga min bɛ ka bɔ kɛnɛ kan fasa furakɛli siratigɛ la, olu bɛ baarakɛcogo ɲuman jira fasa furakɛli la balikuw, denmisɛnw ani mɔgɔ kɛrɛnkɛrɛnnenw na (i n’a fɔ PCOS banabagatɔw) k’a sababu kɛ u kɛcogo kɛrɛnkɛrɛnnen ye. Sira caman fɛ, i n’a fɔ inisɔndiya bɔli sabatili, dumuni nege dabila, ani kɔnɔbara lankolonya bilali kɔfɛ, GLP-1 RAw bɛ banabagatɔw dɛmɛ kosɛbɛ ka u girinya dɔgɔya ani ka farikoloɲɛnajɛ cogoya ɲɛ.
Balikuw ka fasa furakɛli la, furaw i n’a fɔ liraglutide ni semaglutide, olu tiɲɛna kɛnɛyaso sɛgɛsɛgɛliw fɛ, o bɛ furakɛli suguya dannamɔgɔ di fasa banabagatɔw ma. Fasa furakɛli la PCOS banabagatɔw la, GLP-1 RAw tɛ dɛmɛ dɔrɔn ka farikolo girinya dɔgɔya, nka u bɛ farikolojidɛsɛbanaw fana ɲɛ ka ɲɛ, minnu bɛ tali kɛ bana in na, ka nafa caman lase PCOS banabagatɔw ma.
Sosow (Sɔrɔyɔrɔw).
[1] Zhang D, Lu H. GLP-1RA: Jigiya kura fasa furakɛli la[J]. Biosciences ni furakɛli gafe, 2025,13(2):465-479. https://cstj.cqvip.com/Qikan/Article/Detail?id=HS727602025002035. Kalanjɛ ni sɛbɛnni: kalanjɛ ni sɛbɛnni gafew
[2] Kavarian PN, Mosher TL, Haija MA E. Glucagon-like-peptide 1 receptor agoniste tali denmisɛnw ka fasa furakɛli la.[J]. Sisan hakilina denmisɛnw ka kɛnɛyako la, 2024,36 5:542-546. Kalanjɛ ni sɛbɛnni: kalanjɛ ni sɛbɛnni gafew
[3] Wang J. Y., Wang Q. W., Yang X Y., ani a ɲɔgɔnnaw. GLP-1 minɛbagaw ka agonistew fasa furakɛli la: Jɔrɔ ye fɛɛrɛ ye min bɛ layidu ta[J]. Dancɛw ka ɲɛsin Endocrinologie ma, 2023,14:1085799.DOI:10.3389/fendo.2023.1085799.
[4] Pedrosa M. R., Franco D. R., Gieremek H. W., ani mɔgɔ wɛrɛw. GLP-1 Agonist ka fasa furakɛ ani ka dusukunnabana kunbɛn: An ye mun sɔrɔ fɔlɔ?[J]. Sisan joli siraw sɔgɔsɔgɔli kunnafoniw, 2022,24(11):867-884.DOI:10.1007/s11883-022-01062-2.
[5] Baranowska-Bik A. Fasa furakɛli PCOS bɛ musow la ni GLP-1 analoziw ye - nafa ni dan [Terapia otyłości u kobiet z PCOS przy zastosowaniu analogów GLP-1 - korzyści i ograniczenia][J Endokrynologia Polska, 2022,73(3):627-643.DOI:10.5603/EP.a2022.0047. Kalanjɛ ni sɛbɛnni: kalanjɛ ni sɛbɛnni gafew.
